Biotechnology software in the digital age: are you winning?

Overview of attention for article published in Journal of Industrial Microbiology & Biotechnology, July 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 12,608 followers.

RT @paperlessus: "Biotechnology companies that do not adopt the new regime may lose on key business metrics such as return on invested capi…

RT @paperlessus: "Biotechnology companies that do not adopt the new regime may lose on key business metrics such as return on invested capi…

"Biotechnology companies that do not adopt the new regime may lose on key business metrics such as return on invested capital, revenue, profitability, and eventually market share." #ECS #Automation #Labs #Tech #ContentServices https://t.co/wDo99DikJw

RT @cellfreetech: Pretty cool piece about biotech software "coming of age" and comparison to other industries. Key takeaway? Biotech shoul…

Pretty cool piece about biotech software "coming of age" and comparison to other industries. Key takeaway? Biotech should embrace #opensource ! https://t.co/xU6QIBXp7X https://t.co/s8BIJqxTeo

5min read: Biotechnology software in the digital age: are you winning? https://t.co/g0Soif5sfi https://t.co/uwdww7SETn